Please login to the form below

Not currently logged in
Email:
Password:

US government

This page shows the latest US government news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

UK specialist pharma company Summit Therapeutics has been awarded an extra $12m from a US government department to fund development of a new antibiotic. ... The US specialist pharma company has acquired rights to a wide-range of neurology candidates from

Latest news

More from news
Approximately 2 fully matching, plus 195 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified across 15 states of the USA. ... Alongside this, there have been equally important initiatives by the World Health Organization (WHO),

  • US health reforms US health reforms

    US health reforms. Is the stage set for price controls in the US? ... Meanwhile, the global industry waits with bated breath upon a recently elected, mercurial US federal government that whipsaws from one extreme to the other, sometimes within the hour.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    The only ‘fact’is that ‘Brexit means Brexit’… so the Government tell us. ... Two post-referendum announcements have boosted the UK Government. GSK announced a £275 million investment in its UK manufacturing sites and Alnylam, a US biotech

  • Deal Watch August 2016 Deal Watch August 2016

    At the time Deal Watch commented: “ Hopefully Pfizer has finally got the message from the US Government and will now focus on developing its long term business as a leading pharmaceutical ... 624. Advaxis (US). Amgen (US). Licence. ADXS-NEO,

  • Deal Watch April 2016 Deal Watch April 2016

    Winners and losers of the Pfizer/Allergan Fiasco. Winners. Losers. US Government (possibly short term gain). ... This time it is not a Big Pharma deal being blocked by US Government but a Big Pharma deal (by Sanofi ) blocked by Biotech (Medivation).

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Portland Health appoints Alfred Jackson as a partner Portland Health appoints Alfred Jackson as a partner

    In addition to his work in healthcare, Jackson also has broad experience in public affairs and government relations. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our offering to

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Former Sanofi exec Joseph Devaney joins Astellas. He becomes government affairs and policy, Americas VP. ... In this role, Devaney will be responsible for developing, communicating and implementing Astellas' federal and state government strategies in the

  • Pfizer’s CMO joins board of Tenet Pfizer’s CMO joins board of Tenet

    US healthcare services company Tenet Health Corporation has added pharma experience to its board with the appointment of Pfizer's chief medical officer as director. ... In addition to her role at Pfizer Dr Lewis-Hall was appointed by the US Government to

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    Sanofi appoints NIH’ s Gary Nabel as chief scientific officer. He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... Dr Nabel leaves the NIH, which is part of the US government's department of

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Genetic counsellors: the new healthcare influencers?

    The US government will cover the costs, signalling their commitment to more precise treatment that will drive better outcomes for patients across the U.S. ... The wild west of genetic testing. There are more than  70, 000 different genetic testing

  • Packer Forbes News January 2016

    She is a graduate in Politics and Parliamentary Studies from the University of Leeds, where she gained first-hand insight into the UK and US government health systems during her placement

  • Could hackers threaten your health?

    In this year’ s Def Con hacking conference, representatives from the US FDA, the government body responsible for the security of medical devices, spoke for the first time.

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7) A US government survey found that that 94% of $1

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7) A US government survey found that that 94% of $1

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics